OMKARCHEM

Omkar Speciality Chemicals Limited has informed the Exchange regarding the outcome of the Board Meeting of the Company held on June 20, 2014.

Omkar Speciality Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2014.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 10, 2014 has recommended a dividend of Rs. 1.50 (15%) per Equity Share of Rs. 10 each for the Financial Year ended on March 31, 2014.

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated April 01, 2014 a declaration pursuant to regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Moneywise Financial Services Pvt ltd has submitted to the Exchange vide letter dated March 27, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has informed the Exchange that "the new project at our Unit No. VI, located at Plot No.B-15 & B-16, Lote Parshuram Industrial Area, Taluka Khed, Dist: Ratnagiri, PIN - 415722, State: Maharashtra, has been completed and we propose to start the trial runs followed up by regular commercial production very shortly. This plant, with a capacity of 300 MTs per annum, will manufacture advance intermediates for the pharma industry catering to essential life-saving drugs with the state of the art facility for production and quality control. This facility will also cont

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated March 01, 2014 a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations,1992.

Omkar Speciality Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Dec-2013.

Omkar Speciality Chemicals Limited has informed the Exchange, vide letter dated November 23, 2013 regarding the "Acquisition of Plot(s)".

Omkar Speciality Chemicals Limited has informed the Exchange that the Shareholding of the Promoter's Group has been increased from 11,858,816 shares (60.42%) as on September 30, 2013 to 12,569,080 shares (64.04%) as on November 15, 2013, through secondary market acquisitions. Further, the Company has informed that, IDFC Premier Equity Fund (Mutual Fund) has acquired 880,510 shares (4.49%) of the Company in the recent past, from the secondary market.

Omkar Speciality Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-sep-2013.

Moneywise Financial Services Pvt ltd has submitted to the Exchange vide letter dated October 19, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Pravin S Herlekar has submitted to the Exchange vide letter dated October 18, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Omkar P Herlekar has submitted to the Exchange vide letter dated october 18, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has informed the Exchange that "M/s Omkar Speciality Chemicals Limited has acquired the rights of the Plot No. W-93(A), admeasuring about 720 sq.mtrs situated at MIDC, Badlapur (East), Thane - 421503, which earlier belonged to M/s Desh Chemicals Pvt. Ltd., wholly owned subsidiary of the Company, for the operational benefits of the Company".

Omkar Speciality Chemicals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended June 30,2013.

Omkar Speciality Chemicals Limited has submitted to the Exchange the proceedings of Annual General Meeting (AGM) of the Company held on August 13, 2013

Omkar Speciality Chemicals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2013.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 20, 2013 has recommended a dividend of Rs. 1.50 (15%) per Equity Share of Rs. 10 each for the Financial Year ended on March 31, 2013.

Omkar Speciality Chemicals Limited has informed the Exchange that the dividend, if declared, will be credited/dispatched on August 26, 2013 to those members entitled thereto.

Omkar Speciality Chemicals Limited has informed the Exchange that the Company has fixed Book Closure from August 6, 2013 to August 13, 2013 for the purpose of declaration of dividend and Annual General Meeting. of the company which will be held on August 13, 2013.

Omkar Speciality Chemicals Limited has informed the Exchange regarding the Outcome of meeting of Board of Directors of the Company held on March 06, 2013.

Omkar Speciality Chemicals Limited has informed the Exchange that the Members of the Company have passed the following resolution in the Extra Ordinary General Meeting held on February 14, 2013 : (1) Alternation of Articles of Association to give effect to resolution No.2; (2) Issuance of 950,000 preferential Warrants Convertible into Equity Shares of the Company at a price of Rs.150/- per warrant.

Omkar Speciality Chemicals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results along with the Limited Review Report for the period ended December 31,2012.

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated January 18, 2013 a copy of the Notice of the Extra-Ordinary General Meeting of the Members of the Company to be held on February 14, 2013.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 12, 2013 has decided and approved the following, subject to the approval of shareholders through Extra Ordinary General Meeting: (1) Consented for issuance of 950,000 (Nine Lacs Fifty Thousand) Warrants, on preferential basis to the Promoters & Promoter Group, convertible into 950,000 (Nine Lacs Fifty Thousand) Equity Shares of Rs. 10/- (Rupees Ten only) each fully paid-up at a price not less than Rs. 150/- (Rupees One Hundred and Fifty only) per share, determi

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated January 04, 2013 a copy of Revised Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations,1992.

Omkar Speciality Chemicals Limited has informed the Exchange vide letter dated December 24, 2012 regarding "Commissioning of Our New Facility at Urdhwa Chemicals Co. Pvt. Ltd. (Wholly Owned Subsidiary), Chiplun".

Omkar Speciality Chemicals Limited has informed the Exchange vide letter dated November 30, 2012 regarding "Updates on Utilization of our IPO proceeds and status of our various projects".

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on November 03, 2012, has accepted the resignation tendered by Mrs. Swapnali S. Puranik, Company Secretary and Compliance Officer of the Company with effect from October 16, 2012. Further, in the aforesaid Board Meeting, the Board of Directors has appointed, Mr. Nirav Momaya as Company Secretary and Compliance Officer of the Company with effect from October 16, 2012. In consequent to the aforesaid developments, the Company further wish to inform that the authority given

Omkar Speciality Chemicals Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2012.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 03, 2012 discussed and approved the following items : (1) Considered and took note of the resignation of Mrs. Swapnali Puranik, Company Secretary and Compliance Officer of the Company and consequently relived her from the services of the Company with effect from October 16, 2012; (2) Considered and took note of the appointment of Mr. Nirav Momaya as Company Secretary and Compliance Officer of the Company pursuant to Section 383A of the Companies Act, 1956 and

Omkar Speciality Chemicals Limited has submitted to the Exchange a copy of the Minutes of the Annual General Meeting of the Company held on August 04, 2012.

Omkar Speciality Chemicals Limited has submitted to the Exchange a copy of the Proceedings of the Annual General Meeting of the Company held on August 04, 2012.

Omkar Speciality Chemicals Limited has informed the Exchange regarding the Outcome of Annual General Meeting held on August 04, 2012.

Omkar Speciality Chemicals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results along with the Limited Review Report for the period ended June 30, 2012.

Omkar Speciality Chemicals Limited has informed the Exchange that the Annual General Meeting of the Company will be held on August 04, 2012. Further, the Register of Members and Share Transfer Books of the Company will remain closed from July 28, 2012 to August 04, 2012 for the purpose of declaration of dividend and Annual General Meeting.

Omkar Speciality Chemicals Limited has submitted to the Exchange the Outcome of the Board Meeting held on June 26, 2012.

Omkar Speciality Chemicals Limited has informed the Exchange that Ms. Pooja Dandekar Assistant Company Secretary will sign the documents as a Compliance officer of the Company in absence of Mrs. Swapnali Puranik, Company Secretary & compliance officer of the Company.

Omkar Speciality Chemicals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2012.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors at its meeting held on May 19, 2012 have considered and approved the following: (1) Payment of Dividend of Rs. 1.25/- (i.e. 12.5%) per equity share of the Company for the financial year ended on March 31, 2012. (Subject to members' approval)

Omkar Speciality Chemicals Limited has informed the Exchange that a Press Conference of the Company will be held on May 14, 2012 to discuss about the Company's various projects and prospects and also to explore the possibilities of investments by the Company in the state of Goa if any in the Company's existing line of operations such as setting-up a R&D Facility etc.

Omkar Speciality Chemicals Limited has informed the Exchange that the Company has been accorded the coveted status of 'Star Export House' in accordance with the provisions of the Foreign Trade Policy, 2009-2014 by the Ministry of Commerce and Industry, Department of Commerce, Government of India. This makes OSCL eligible for many privileges that will help enhance its business and exports revenues. This is the highest recognition given to OSCL, based on its cumulative value of exports in the past couple of years, along with consistent export track record and continual growth in turnover and for

Omkar Speciality Chemicals Limited has submitted to the Exchange vide its letter dated April 20, 2012, a copy of Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Further, the company has submitted to the Exchange vide its letter dated April 21, 2012 a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Rohinton Screwvala has submitted to the Exchange, vide letter dated April 20, 2012 a copy of Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has informed the Exchange vide its letter dated April 16, 2012 with reference to the news article dated April 10, 2012, bearing headline: "Omkar Chemicals to invest Rs. 100 Crore in new Chiplun facility". Omkar Speciality Chemicals Limited has clarified to the Exchange that there is misconstruction of facts in the aforesaid article. The said proposed expansion of the Company is a part of the Company's strategic growth policy driven by the market demands and the Company proposes to fund these expansions out of internal accruals and suitable bank borrowings. Th

Omkar Speciality Chemicals Limited has informed the Exchange regarding the outcome of Board Meeting of the Company held on April 05, 2012.

Omkar Speciality Chemicals Limited has informed the Exchange that a Press Conference of the Company will be held on April 10, 2012 to discuss about the Company's venture into pharmaceutical business with its recent acquisition of LASA Laboratory Private Limited.

Omkar Speciality Chemicals Limited has informed the Exchange that the Company have forayed into pharmaceutical business with the Company's recent acquisition of LASA Laboratory Private Limited located at Mahad in Raigad district, which has been an established player in the anthelmintic/ veterinary API segment with state-of-the-art API manufacturing facility.

Omkar Speciality Chemicals Limited has informed the Exchange regarding the outcome of Board Meeting of the Company held on March 07, 2012.